Timo Hagen

510 total citations
15 papers, 391 citations indexed

About

Timo Hagen is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Timo Hagen has authored 15 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Oncology. Recurrent topics in Timo Hagen's work include RNA and protein synthesis mechanisms (4 papers), DNA and Nucleic Acid Chemistry (3 papers) and CAR-T cell therapy research (2 papers). Timo Hagen is often cited by papers focused on RNA and protein synthesis mechanisms (4 papers), DNA and Nucleic Acid Chemistry (3 papers) and CAR-T cell therapy research (2 papers). Timo Hagen collaborates with scholars based in Netherlands, Switzerland and United States. Timo Hagen's co-authors include Jonathan Hall, Helen L. Lightfoot, Natalie J. Tatum, Т. Ф. Степанова, Ron Smits, Ksenija Drabek, Anna Akhmanova, Niels Galjart, Carmen Laura Sayas and Marco van Ham and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Nature Methods.

In The Last Decade

Timo Hagen

13 papers receiving 384 citations

Peers

Countries citing papers authored by Timo Hagen

Since Specialization

Citations

This map shows the geographic impact of Timo Hagen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Hagen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Hagen more than expected).

Fields of papers citing papers by Timo Hagen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Hagen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Hagen. The network helps show where Timo Hagen may publish in the future.

Co-authorship network of co-authors of Timo Hagen

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Hagen. A scholar is included among the top collaborators of Timo Hagen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Hagen. Timo Hagen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	A portable poison exon for small-molecule control of mammalian gene expression 2025 ·Nature Methods ·(unknown), Maxim Oleynikov, Xiaohan Mei, (unknown), Timo Hagen, Samie R. Jaffrey	0
2	Engineering acyclovir-induced RNA nanodevices for reversible and tunable control of aptamer function 2024 ·Cell chemical biology ·Timo Hagen, Jacob L. Litke, (unknown), (unknown), Samie R. Jaffrey	0
3	Inosine Substitutions in RNA Activate Latent G-Quadruplexes 2021 ·Journal of the American Chemical Society ·Timo Hagen, (unknown), Anneke Brümmer, (unknown), (unknown), Antoine Cléry, Frédéric H.‐T. Allain, Renato Zenobi, Sven Bergmann, Jonathan Hall	14
4	Site-Specific Fluorophore Labeling of Guanosines in RNA G-Quadruplexes 2019 ·ACS Omega ·Timo Hagen, A. Malinowska, Helen L. Lightfoot, (unknown), Jonathan Hall	4
5	The diverse structural landscape of quadruplexes 2019 ·FEBS Letters ·Helen L. Lightfoot, Timo Hagen, Natalie J. Tatum, Jonathan Hall	104
6	Control of the polyamine biosynthesis pathway by G2-quadruplexes 2018 ·eLife ·Helen L. Lightfoot, Timo Hagen, Antoine Cléry, Frédéric H.‐T. Allain, Jonathan Hall	21
7	Abstract 1370: Activin receptor-like kinase 1 ligand trap reduces microvascular density and improves chemotherapy efficiency to various solid tumors 2015 ·Cancer Research ·Lukas J.A.C. Hawinkels, Amaya García de Vinuesa, Madelon Paauwe, Marianna Kruithof‐de Julio, (unknown), Marie‐José Goumans, Timo Hagen, Peter ten Dijke	1
8	Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cells 2010 ·Cancer Immunology Immunotherapy ·Nadine Pouw, (unknown), Jaco Kraan, Floyd Wittink, Timo Hagen, Jaap Verweij, Reno Debets	55
9	Serum concentrations of pegylated interferon α-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon α-2b in a randomized phase III trial (EORTC 18991) 2009 ·Cancer Chemotherapy and Pharmacology ·Alexander M.M. Eggermont, Marna G. Bouwhuis, Wim H.J. Kruit, Alessandro Testori, Timo Hagen, Antoine Yver, Christine Xu	14
10	Serum S-100B protein is a strong independent prognostic marker for distant-metastasis free survival (DMFS) in stage III melanoma patients: An evaluation of the EORTC randomized trial 18952 comparing IFNα versus observation 2007 ·Journal of Clinical Oncology ·Stefan Suciu, G. Ghanem, (unknown), Konstantin Stoitchkov, Poulam M. Patel, M. Delaunay, Timo Hagen, E. Musat, (unknown), A.M.M. Eggermont	4
11	Prognostic value of autoantibodies (auto-AB) in melanoma patients (pts) in the EORTC 18952 trial of adjuvant interferon (IFN) compared to observation (obs) 2007 ·Journal of Clinical Oncology ·Marna G. Bouwhuis, Stefan Suciu, (unknown), François Salès, Palak Patel, C.J.A. Punt, Konstantin Stoitchkov, M. Delaunay, Timo Hagen, A.M.M. Eggermont	8
12	Role of CLASP2 in Microtubule Stabilization and the Regulation of Persistent Motility 2006 ·Current Biology ·Ksenija Drabek, Marco van Ham, Т. Ф. Степанова, (unknown), Remco van Horssen, Carmen Laura Sayas, Anna Akhmanova, Timo Hagen, Ron Smits, Riccardo Fodde, Frank Grosveld, Niels Galjart	127
13	Gene Therapy in In Vivo Isolated Perfusion Models 2005 ·Current Gene Therapy ·Boudewijn van Etten, Alexander M.M. Eggermont, Sandra T. van Tiel, (unknown), Johannes H.W. de Wilt, Timo Hagen	9
14	Immunohistological analysis of immune cell infiltration of a human colon tumor xenograft after treatment with Stealth® liposome-encapsulated tumor necrosis factor-α and radiation 2002 ·International Journal of Oncology ·Dong Woo Kim, Melba L. Andres, (unknown), (unknown), (unknown), Ann L.B. Seynhaeve, Timo Hagen, Daila S. Gridley	6
15	Nepal: The Kingdom in the Himalayas 1962 ·Geographical Journal ·(unknown), Timo Hagen	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact